2002
DOI: 10.1016/s0006-2952(02)01287-x
|View full text |Cite
|
Sign up to set email alerts
|

Complementary DNA cloning and characterization of cytochrome P450 2D29 from Japanese monkey liver

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
18
0

Year Published

2004
2004
2010
2010

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 26 publications
0
18
0
Order By: Relevance
“…Assay of Drug Oxidation Activities ---DB 4-hydroxylase activity was measured by the HPLC method reported previously. 6) Briefly, a 500-µl incubation mixture in an Eppendorf-type tube (1.5 ml) contained 10 pmol of CYP, 5 mM G-6-P, 1 IU of G-6-P dehydrogenase, 5 mM MgCl 2 , 0.1 mM EDTA, 0.5 mM NADPH and 100 µM DB in 100 mM potassium phosphate buffer (pH 7.4). After a 5-min preincubation at 37°C, the reaction was started by adding NADPH and continued for 5 min.…”
Section: )mentioning
confidence: 99%
See 2 more Smart Citations
“…Assay of Drug Oxidation Activities ---DB 4-hydroxylase activity was measured by the HPLC method reported previously. 6) Briefly, a 500-µl incubation mixture in an Eppendorf-type tube (1.5 ml) contained 10 pmol of CYP, 5 mM G-6-P, 1 IU of G-6-P dehydrogenase, 5 mM MgCl 2 , 0.1 mM EDTA, 0.5 mM NADPH and 100 µM DB in 100 mM potassium phosphate buffer (pH 7.4). After a 5-min preincubation at 37°C, the reaction was started by adding NADPH and continued for 5 min.…”
Section: )mentioning
confidence: 99%
“…6) Briefly, a 500 µl incubation mixture in a brown glass conical tube (10 ml) with a glass stopper contained 10 pmol CYP, 5 mM G-6-P, 1 IU of G-6-P dehydrogenase, 5 mM MgCl 2 , 0.1 mM EDTA, 0.5 mM NADPH and 100 µM BF racemate in 100 mM potassium phosphate buffer (pH 7.4). Manipulations hereafter were the same as those employed in the assay of BTL 4-hydroxylation except for using propranolol racemate (100 nmol) instead of procainamide as an internal standard.…”
Section: )mentioning
confidence: 99%
See 1 more Smart Citation
“…The former two are used routinely in preclinical studies. Cynomolgus monkey CYP2D17 (Mankowski et al, 1999) and Japanese monkey CYP2D29 (Hichiya et al, 2002) have been identified and characterized in macaques. Rhesus monkey CYP2D42 cDNA, nearly 98% homologous to cynomolgus monkey CYP2D17 cDNA, has been isolated and its sequence can be found in GenBank.…”
Section: Introductionmentioning
confidence: 99%
“…Deduced amino acid sequences of these CYP2D cDNAs share high sequence identity (93-96%) with human CYP2D6. Cynomolgus monkey CYP2D17 and Japanese monkey CYP2D29 metabolize typical human CYP2D6 substrates; CYP2D17 metabolizes bufuralol and dextromethorphan, whereas CYP2D29 metabolizes bufuralol and debrisoquine (Mankowski et al, 1999;Hichiya et al, 2002). Moreover, cynomolgus monkey CYP2D17 and Japanese monkey CYP2D29 enzymatic activities are inhibited by the CYP2D6 inhibitor quinidine, indicating that these macaque CYP2Ds have functional characteristics similar to those of human CYP2D6.…”
Section: Introductionmentioning
confidence: 99%